Resource Library

Search All Resources

  • Clear All
Cirrhotic Ascites | January 17, 2024

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #ascites  #cirrhosis  #hcv  #management  #paracentesis  

In this presentation Richard Manch, MD, discusses management of patients with ascites. He discusses the indications and contraindications for paracentesis, initial laboratory investigation of ascitic fluid, the core elements for treatment of ascites (including sodium restriction, appropriate use of diuretics, ...

Date added: 01/17/24

Harm Reduction 101: Starting a Program at I/T/U Sites | December 6, 2023

Type: Past Presentation  Training  

Audience: Clinical  

Program: Ending the Epidemics in Indian Country ECHO Program  Hepatitis C  

Keywords: #community education  #naloxone  #Red Lake  #syringe services  

In this presentation, Samantha Gustafson, PharmD, describes the benefits of harm reduction services, such as syringe exchange and naloxone deployment, defines the components of comprehensive harm reduction services, and discusses ways to apply planning strategies to develop and implement effective ...

Date added: 12/3/23

Updates in CDC HCV Testing Recommendations | November 15, 2023

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #children screening  #hcv  #hcv monitoring  #hcv testing  #hep c  #hepatitis  #perinatal  

In this presentation, Dr. Paulina Deming describes the risk of HCV infection in perinatally exposed children and identifies when children with perinatal exposure should be tested for HCV.  

Date added: 11/13/23

PrEP 101: Pre-exposure Prophylaxis for HIV | November 1, 2023

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #hiv  #pre-exposure prophylaxis  #prep  

In this presentation, Dr. Heather Huentelman, Clinical Pharmacist at Phoenix Indian Medical Center shares her story of why she chose to start providing Pre-Exposure Prophylaxis (PrEP) – a highly effective and safe intervention that prevents the transmission of HIV. Dr. ...

Date added: 10/30/23

Medication Management of Depression | October 25, 2023

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #depression  #medications  #pharmacotherapy  

In this presentation, Dr. Jasen Christensen, DO, discusses the range of antidepressants available, reasons to choose and reasons to avoid certain antidepressants, and reviews the importance of antidepressant treatment duration.    

Date added: 10/20/23

Screening for Hepatocellular Carcinoma | October 18, 2023

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #hcc  #hepatocellular carcinoma  

Incidence of hepatocellular carcinoma (HCC) is rising quickly in the United States, and AI/AN people are being affected greater than any other group. In this presentation, Dr. Jon Gerry, surgeon and physician at Franz Liver Cancer Clinic, Providence Portland Medical ...

Date added: 10/7/23

Common HCV DAA Drug Interactions | September 27, 2023

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #drug interactions  #hcv  #hcv monitoring  #hcv treatment  #hep c  #hepatitis  #medications  

In this presentation, Dr. Paulina Deming describes the interaction potential between DAA therapies and common medications, and identifies when DAA therapies and diabetic medications are most likely to result in hypoglycemia.  

Date added: 09/25/23

Recognizing Cirrhosis | September 6, 2023

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #cirrhosis  #fibrosis  #hcv  

In this presentation, Dr. Karla Thornton discusses the natural history of chronic liver disease, how to recognize cirrhosis and steps to take after determining someone has cirrhosis.  

Date added: 08/29/23

HCV Treatment Monitoring: Keeping it Simple | August 23, 2023

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #hcv  #hcv cure  #hcv monitoring  #hcv treatment  #hep c  #hepatitis  

In this session, Dr. Paulina Deming discusses baseline laboratories recommended for HCV treatment evaluation, identifies patients eligible for simplified monitoring and shares HCV treatment monitoring recommendations.

Date added: 08/16/23

Evaluation of Infectious Diseases in People With Substance Use Disorders: An Opportunity for Disease Elimination | August 16, 2023

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #hcv  #infectious disease  #mat  #pharmacotherapy  #prevention  #Screening  #substance use  #SUD  #treatment  

In this presentation Jorge Mera, MD, discusses evaluation of infectious diseases for people with substance use disorders. He discusses the syndemic of HIV, HCV, STIs and SUDs, the intersection between infectious disease and substance use disorder and the importance of ...

Date added: 08/13/23